High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission

PURPOSE: We conducted two World Health Organization-commissioned reviews to inform use of high-flow nasal cannula (HFNC) in patients with coronavirus disease (COVID-19). We synthesized the evidence regarding efficacy and safety (review 1), as well as risks of droplet dispersion, aerosol generation,...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, Arnav, Basmaji, John, Muttalib, Fiona, Granton, David, Chaudhuri, Dipayan, Chetan, Devin, Hu, Malini, Fernando, Shannon M., Honarmand, Kimia, Bakaa, Layla, Brar, Sonia, Rochwerg, Bram, Adhikari, Neill K., Lamontagne, Francois, Murthy, Srinivas, Hui, David S. C., Gomersall, Charles, Mubareka, Samira, Diaz, Janet V., Burns, Karen E. A., Couban, Rachel, Ibrahim, Quazi, Guyatt, Gordon H., Vandvik, Per O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Review Article/Brief Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294988/
https://www.ncbi.nlm.nih.gov/pubmed/32542464
http://dx.doi.org/10.1007/s12630-020-01740-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294988/
https://www.ncbi.nlm.nih.gov/pubmed/32542464
http://dx.doi.org/10.1007/s12630-020-01740-2

Ejemplares similares